SAN FRANCISCO–(BUSINESS WIRE)–People.ai, the leading AI data platform for sales teams, today announced a Model Context Protocol (MCP) integration for its SalesAI Platform, enabling revenue teams to access complete revenue intelligence – including both structured and unstructured data – directly within their existing AI workflows. Read more...
Read MoreSan Francisco, CA — February 18, 2026 — Crusoe, the industry’s first vertically integrated AI infrastructure provider, today announced the launch of Command Center, a unified operations platform designed to increase the resilience of the entire AI stack by providing a high-fidelity data foundation for massive AI workloads. Read...
Read MoreBINYAMINA, Israel and CARY, N.C., Feb. 18, 2026 /PRNewswire/ — OncoHost, a technology company transforming precision oncology through proteomics and AI, today announced the publication of a new study in the Journal of Pharmaceutical and Biomedical Analysis (JPBA), titled “Bridging the Gap: A Systematic Approach to Integrating Serum and Plasma Proteomic Datasets for Biomarker Studies.” Read more...
Read MoreBINYAMINA, Israel and CARY, N.C., Feb. 18, 2026 /PRNewswire/ — OncoHost, a technology company transforming precision oncology through proteomics and AI, today announced the publication of a new study in the Journal of Pharmaceutical and Biomedical Analysis (JPBA), titled “Bridging the Gap: A Systematic Approach to Integrating Serum and Plasma Proteomic Datasets for Biomarker Studies.” Read more...
Read MoreHUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, today announced that Aetna has issued a prior authorization for a Medicare Advantage beneficiary to obtain the ReWalk Personal Exoskeleton, recognizing the device as medically necessary for a qualifying individual living with spinal cord injury. Read more...
Read More
